MyFinsight
Home
About
Contact
kros: the income statement
Download
Download image
Net income (loss)
-$7,280K
(86.25%↑ Y/Y)
Income tax (provision)
benefit
-$1,424K
Dividend income
$6,933K
(19.68%↑ Y/Y)
Income (loss) before
income taxes
-$8,704K
Total other income,
net
$6,680K
(17.17%↑ Y/Y)
License
$10,000K
Service Other
$4,262K
Other expense, net
-$253K
(-175.00%↓ Y/Y)
Income (loss) from
operations
-$15,384K
(73.77%↑ Y/Y)
Total revenue
$14,262K
(3575.77%↑ Y/Y)
Total operating
expenses
$29,646K
(-49.79%↓ Y/Y)
General and
administrative
$10,127K
(3.13%↑ Y/Y)
Research and development
$19,519K
(-60.35%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Keros Therapeutics, Inc. (KROS)
Keros Therapeutics, Inc. (KROS)